Insider Transactions in Q4 2023 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
Terry J Rosen Chief Executive Officer |
BUY
Acquisition or disposition by will or laws
|
Direct |
448
+0.01%
|
-
|
|
Dec 22
2023
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
21,521
-7.68%
|
$365,857
$17.76 P/Share
|
|
Dec 20
2023
|
Alexander Azoy Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
68
-0.66%
|
$1,224
$18.21 P/Share
|
|
Dec 19
2023
|
Jennifer Jarrett Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,492
-3.94%
|
$206,856
$18.09 P/Share
|
|
Dec 19
2023
|
Ii Robert C. Goeltz Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,808
-4.96%
|
$50,544
$18.09 P/Share
|
|
Dec 19
2023
|
Alexander Azoy Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
661
-6.04%
|
$11,898
$18.09 P/Share
|
|
Dec 19
2023
|
Dimitry Sa Nuyten Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,540
-2.12%
|
$27,720
$18.09 P/Share
|
|
Dec 19
2023
|
Carolyn C. Tang General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,076
-4.43%
|
$73,368
$18.09 P/Share
|
|
Dec 19
2023
|
Terry J Rosen Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,000
-0.36%
|
$252,000
$18.09 P/Share
|
|
Dec 19
2023
|
Juan C. Jaen President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,259
-2.03%
|
$112,662
$18.09 P/Share
|
|
Dec 18
2023
|
Jennifer Jarrett Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,250
-3.71%
|
$191,250
$17.74 P/Share
|
|
Dec 18
2023
|
Ii Robert C. Goeltz Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,749
-4.63%
|
$46,733
$17.74 P/Share
|
|
Dec 18
2023
|
Alexander Azoy Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
647
-5.58%
|
$10,999
$17.74 P/Share
|
|
Dec 18
2023
|
Dimitry Sa Nuyten Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,507
-2.03%
|
$25,619
$17.74 P/Share
|
|
Dec 18
2023
|
Carolyn C. Tang General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,991
-4.16%
|
$67,847
$17.74 P/Share
|
|
Dec 18
2023
|
Terry J Rosen Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,705
-0.35%
|
$232,985
$17.74 P/Share
|
|
Dec 18
2023
|
Juan C. Jaen President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,128
-1.95%
|
$104,176
$17.74 P/Share
|
|
Dec 01
2023
|
Alexander Azoy Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
282
-2.37%
|
$3,948
$14.95 P/Share
|